Our findings pioneer the investigation into the critical role of B4GALNT1 in HCC, especially in the context of tumor progression and immunosuppression, which advances the understanding of HCC pathogenesis and lays the groundwork for developing more precise and personalized treatment plans. This evidence concerns the gene B4GALNT1 and hepatocellular carcinoma.